HR 3503
NIH Clinical Trial Diversity Act of 2023
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The NIH Clinical Trial Diversity Act of 2023 aims to increase diversity in clinical trials by requiring sponsors to establish specific goals for recruiting and retaining participants from various racial, ethnic, age, and sex groups. It mandates that clinical trial protocols include plans for achieving these goals, implementing less burdensome follow-up requirements, and providing education to researchers about diversity in trials. The bill also requires sponsors to share demographic data with the NIH, promotes a national awareness campaign, and directs studies on barriers to participation and potential regulatory reforms.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Anna G. Eshoo
Becca [D-VT-At Large] Balint
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.